Insulin, Insulin Resistance, and Dyslipidemia
1993; Wiley; Volume: 683; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1993.tb35687.x
ISSN1749-6632
Autores Tópico(s)Metabolism, Diabetes, and Cancer
ResumoAnnals of the New York Academy of SciencesVolume 683, Issue 1 p. 1-8 Insulin, Insulin Resistance, and Dyslipidemia BARBARA V. HOWARD, BARBARA V. HOWARD Medlantic Research Institute Washington, DC 20010Search for more papers by this author BARBARA V. HOWARD, BARBARA V. HOWARD Medlantic Research Institute Washington, DC 20010Search for more papers by this author First published: June 1993 https://doi.org/10.1111/j.1749-6632.1993.tb35687.xCitations: 8AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 De FRONZO, R. A. & E. FERRANNINI 1991 Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173–194. 10.2337/diacare.14.3.173 PubMedWeb of Science®Google Scholar 2 REAVEN, G. M. 1988 Role of insulin resistance in human disease. Diabetes 37: 1595–1607. 10.2337/diab.37.12.1595 CASPubMedWeb of Science®Google Scholar 3 KAPLAN, N. M. 1989 The deadly quartet. Arch Intern. Med. 149: 1514–1520. CASPubMedWeb of Science®Google Scholar 4 GLUECK, C. J., R. I. LEVY & D. S. FREDERICKSON 1969 Immunoreactive Insulin, glucose tolerance, and carbohydrate inducibility in Types II, III, IV, and V hyperlipoproteinemia. Diabetes 18: 739–747. 10.2337/diab.18.11.739 CASPubMedWeb of Science®Google Scholar 5 REAVEN, G. M., R. L. LERNER, M. P. STERN & J. W. FARQUHAR 1967 Role of insulin in endogenous hypertriglyceridemia. J. Clin. Invest. 46: 1756–1767. 10.1172/JCI105666 CASPubMedWeb of Science®Google Scholar 6 BRUNZELL, J. O., A. CHAIT & E. L. BIERMAN 1978 Pathophysiology of lipoprotein transport. Metabolism 27: 1109–1127. 10.1016/0026-0495(78)90157-9 CASPubMedWeb of Science®Google Scholar 7 ORCHARD, T. J., D. J. BECKER, M. BATES, L. H. KULLER & A. L. DRASH 1983 Plasma insulin and lipoprotein concentrations: An atherogenic association? Am. J. Epidemiol. 118: 326–337. PubMedWeb of Science®Google Scholar 8 HOWARD, B. V., W. C. KNOWLER, B. VASQUEZ, A. L. KENNEDY, D. J. PETTITT & P. H. BENNETT 1984 Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Arteriosclerosis 4: 462–471. 10.1161/01.ATV.4.5.462 CASPubMedWeb of Science®Google Scholar 9 CAMBIEN, F., J. M. WARNET, E. ESCHWEGE, A. JACQUESON, J. L. RICHARD & G. ROSSELIN 1987 Body mass, blood pressure, glucose, and lipids, does plasma insulin explain their relationships? Arteriosclerosis 7: 197–202. 10.1161/01.ATV.7.2.197 CASPubMedWeb of Science®Google Scholar 10 DONAHUE, R. P., T. J. ORCHARD, D. J. BECKER, L. H. KULLER & A. L. DRASH 1987 Sex differences in the coronary heart disease risk profile: A possible role for insulin. Am. J. Epidemiol. 125: 650–657. CASPubMedWeb of Science®Google Scholar 11 HAFFNER, S. M., D. FONG, H. P. HAZUDA, J. A. PUGH & J. K. PATTERSON 1988 Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 37: 338–345. 10.1016/0026-0495(88)90133-3 CASPubMedWeb of Science®Google Scholar 12 BURCHFIEL, C. M., R. F. HAMMAN, J. A. MARSHALL, J. BAXTER, L. B. KAHN & J. J. AMIRANT 1990 Cardiovascular risk factors and impaired glucose tolerance: The San Luis Valley diabetes study. Am J. Epidemiol. 131: 57–70. 10.1093/oxfordjournals.aje.a115485 CASPubMedWeb of Science®Google Scholar 13 MCKEIGUE, P. M., G. J. MILLER & M. G. MARMOT 1989 Coronary heart disease in South Asians overseas: A review. J. Clin. Epidemiol. 42: 597–609. 10.1016/0895-4356(89)90002-4 PubMedWeb of Science®Google Scholar 14 MODAN M., H. HALKIN, A. LUSKY, P. SEGAL, A. FUCHS & A. CHETRIT 1988 Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. Arteriosclerosis 8: 227–236. 10.1161/01.ATV.8.3.227 CASPubMedWeb of Science®Google Scholar 15 ZAVARONI, I., E. DALL'ANGLIO, O. ALPI, F. BRUSCHI, E. BONORA, A. PEZZAROSSA & U. BUTTURINI 1985 Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis. 55: 259–266. 10.1016/0021-9150(85)90105-4 CASPubMedWeb of Science®Google Scholar 16 MANOLIO, T. A., P. J. SAVAGE, G. L. BURKE, K. LIU, L. E. WAGENKNECHT, S. SIDNEY, D. R. JACOBS, J. M. ROSEMAN, R. P. DONAHUE & A. OBERMAN 1990 Association of fasting insulin with blood pressure and lipids in young adults. Arteriosclerosis 10: 430–436. 10.1161/01.ATV.10.3.430 CASPubMedWeb of Science®Google Scholar 17 WINOCOUR, P. H., S. KALUVYA, K. RAMAIYA, L. BROWN, J. P. MILLAR, M. FARRER, H. ANDREW, W. NEIL, M. F. LAKER, K. GEORGE & M. M. ALBERTI 1992 Relation between insulinemia, body mass index, and lipoprotein composition in healthy, nondiabetic men and women. Arteriosclerosis Thromb. 12: 393–402. 10.1161/01.ATV.12.3.393 CASPubMedWeb of Science®Google Scholar 18 LEE, E. T., T. K. WELTY, R. FABSITZ, L. D. COWAN, N. A. LE, A. J. OOPIK, A. J. CUCCHIARA, P. J. SAVAGE & B. V. HOWARD 1990 The strong heart study: A study of cardiovascular disease in American Indians: Design and methods. Am. J. Epidemiol. 132: 1141–1155. 10.1093/oxfordjournals.aje.a115757 PubMedWeb of Science®Google Scholar 19 BERNSTEIN, R. M., B. M. DAVIS, J. M. QZLETSKY & G. M. REAVEN 1978 Hepatic insulin responsiveness in patients with endogenous hypertriglyceridemia. Diabetologia 14: 249–253. 10.1007/BF01219424 CASPubMedWeb of Science®Google Scholar 20 ABBOTT, W. G. H., S. LILLIOJA, A. A. YOUNG, J. K. ZAWADZKI, H. YKI-JARVINEN, L. CHRISTIN & B. V. HOWARD 1987 Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes 36: 897–904. 10.2337/diab.36.8.897 CASPubMedWeb of Science®Google Scholar 21 GARG, A. J., H. HELDERMAN, M. KOFFLER, R. AYUSO, J. ROSENSTOCK & P. RASKIN 1988 Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism 37: 982–987. 10.1016/0026-0495(88)90157-6 CASPubMedWeb of Science®Google Scholar 22 LAAKSO, M., H. SARLUND & L. MYKKANEN 1990 Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 10: 223–231. 10.1161/01.ATV.10.2.223 CASPubMedWeb of Science®Google Scholar 23 OWEN, O. E., B. S. B. BLOCK, M. PATEL, G. BODEN, M. MCDONOUGH, T. KREULEN, C. R. SHUMAN & G. A. REICHARD 1977 Human splanchnic metabolism during diabetic ketoacidosis. Metabolism 26: 381–398. 10.1016/0026-0495(77)90105-6 CASPubMedWeb of Science®Google Scholar 24 SPARKS, C. E., J. D. SPARKS, M. BOLOGNINO, A. SALHANICK, P. S. STRUMPH & J. M. AMATRUDE 1986 Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes. Metabolism 35: 1128–1136. 10.1016/0026-0495(86)90026-0 CASPubMedWeb of Science®Google Scholar 25 HOWARD, B. V. 1987 Lipoprotein metabolism in diabetes mellitus. J. Lipid Res. 28: 613–628. 10.1016/S0022-2275(20)38659-4 CASPubMedWeb of Science®Google Scholar 26 PYKALLSTO, O. J., P. H. SMITH & J. D. BRUNZELL 1975 Determinants of human adipose tissue lipoprotein lipase: Effect of diabetes and obesity on basal and diet induced activity. J. Clin. Invest. 56: 1108–1117. 10.1172/JCI108185 PubMedWeb of Science®Google Scholar 27 FUJIOKA, S., Y. MATSUZAWA, K. TOKUNAGE & S. TARUI 1987 Contribution of intraabdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36: 54–59. 10.1016/0026-0495(87)90063-1 CASPubMedWeb of Science®Google Scholar 28 ANDERSON, A. J., K. A. SOBOCINSKI, D. S. FREEDMAN, J. J. BARBORIAK, A. A. RIMM & H. W. GRUCHOW 1988 Body fat distribution, plasma lipids, and lipoproteins. Arteriosclerosis 8: 88–94. 10.1161/01.ATV.8.1.88 CASPubMedWeb of Science®Google Scholar 29 YKI-JARVINEN, H. & M. R. TASKINEN 1988 Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia. Diabetes 37: 1271–1278. 10.2337/diabetes.37.9.1271 CASPubMedWeb of Science®Google Scholar 30 CHAIT, A., E. L. BIERMAN & J. L. ALBERS 1979 Low-density lipoprotein receptor activity in cultured human skin fibroblasts. J. Clin. Invest. 64: 1309–1319. 10.1172/JCI109587 CASPubMedWeb of Science®Google Scholar 31 MAZZONE, T., D. FOSTER & A. CHAIT 1984 In vivo stimulation of low-density lipoprotein degradation by insulin. Diabetes 33: 333–338. 10.2337/diabetes.33.4.333 CASPubMedWeb of Science®Google Scholar 32 BARAKAT, H. A., J. W. CARPENTER, V. D. MCLENDON, P. KHAZANIE, N. LEGGETT, J. HEATH & R. MARKS 1990 Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Diabetes 39: 1527–1533. 10.2337/diabetes.39.12.1527 CASPubMedWeb of Science®Google Scholar 33 BERLINER, A., H. J. L. FRANK, D. KARASIC & M. CAPDEVILLE 1984 Lipoprotein-induced insulin resistance in aortic endothelium. Diabetes 33: 1039–1044. 10.2337/diabetes.33.11.1039 PubMedWeb of Science®Google Scholar 34 BIEGER, W. P., G. MICHEL, D. BARWICH, K. BIEHL & A. WIRTH 1984 Diminished insulin receptors on monocytes and erythrocytes in hypertriglyceridemia. Metabolism 33: 982–987. 10.1016/0026-0495(84)90224-5 CASPubMedWeb of Science®Google Scholar 35 BEVILACQUA, S., R. BONADONNA, G. BUZZIGOLI, C. BONI, D. CIOCIARO, F. MACCARI, M. A. GIORICO & E. FERRANNINI 1987 Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metabolism 36: 502–506. 10.1016/0026-0495(87)90051-5 CASPubMedWeb of Science®Google Scholar 36 THIEBAUD, D., R. A. De FRONZO, E. JACOT, A. GOLAY, K. ACHESON, E. MAEDER & J. P. FELBER 1982 Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism 31: 1128–1136. 10.1016/0026-0495(82)90163-9 CASPubMedWeb of Science®Google Scholar Citing Literature Volume683, Issue1Dietary Lipids and Insulin Action: Proceedings of the Second International Smolenice Insulin SymposiumJune 1993Pages 1-8 ReferencesRelatedInformation
Referência(s)